Oncoplastic mammoplasty as a strategy for reducing reconstructive complications associated with postmastectomy radiation therapy

Breast Journal

Volumn 20, Issue 3, 2014, Pages 302-307

  Peled, Anne Warren ^a   Sbitany, Hani ^a   Foster, Robert D ^a   Esserman, Laura J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

breast reconstruction; neo adjuvant chemotherapy for breast cancer; oncoplastic breast surgery

Indexed keywords

ADULT; BREAST CANCER; BREAST DISEASE; BREAST RECONSTRUCTION; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT NECROSIS; HUMAN; MASTECTOMY; POSTMASTECTOMY RADIATION THERAPY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; REOPERATION; TREATMENT OUTCOME; WOUND DEHISCENCE; WOUND HEALING IMPAIRMENT; ADJUVANT CHEMOTHERAPY; ADVERSE EFFECTS; BREAST NEOPLASMS; CLINICAL TRIAL; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROCEDURES; SEGMENTAL MASTECTOMY; SURGICAL FLAPS;

ADULT; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMAPLASTY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SURGICAL FLAPS; TREATMENT OUTCOME;

EID: 84899112176     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12257     Document Type: Conference Paper

References (33)

1. Taylor ME, Haffty BG, Rabinovitch R, et al,. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology- breast. Int J Radiat Oncol Biol Phys 2009; 15: 997-1002.
2. Recht A, Edge SB, Solin LJ, et al,. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19: 1539-69.
3. Kronowitz SJ, Lam C, Terefe W, et al,. A multidisciplinary protocol for planned skin-preserving delayed breast reconstruction for patients with locally advanced breast cancer requiring postmastectomy radiation therapy: 3-year follow-up. Plast Reconstr Surg 2011; 127: 2154-66.
4. Berry T, Brooks S, Sydow N, et al,. Complication rates of radiation on tissue expander and autologous tissue breast reconstruction. Ann Surg Oncol 2010; 17: 202-10.
5. Brooks S, Djohan R, Tendulkar R, Nutter B, Lyons J, Dietz J,. Risk factors for complications of radiation therapy on tissue expander breast reconstruction. Breast J 2012; 18: 28-34.
6. Nahabedian MY, Tsangaris T, Momen B, Manson PN,. Infectious complications following breast reconstruction with expanders and implants. Plast Reconst Surg 2003; 112: 467-76.
7. Warren Peled A, Stover AC, Foster RD, McGrath MM, Hwang ES,. Long-term reconstructive outcomes after expander-implant breast reconstruction with serious infectious or wound-healing complications. Ann Plast Surg 2012; 68: 369-73.
8. Spear SL, Onyewu C,. Staged breast reconstruction with saline-filled implants in the irradiated breast: recent trends and therapeutic implications. Plast Reconstr Surg 2000; 105: 930-42.
9. Esserman LJ, Berry DA, DeMichele A, et al,. Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL. J Clin Oncol 2012; 30: 3242-9.
10. Sweeting RS, Klauber-Demore N, Meyers MO, et al,. Young women with locally advanced breast cancer who achieve breast conservation after neoadjuvant chemotherapy have a low local recurrence rate. Am Surg 2011; 77: 850-5.
11. Mukhtar RA, Hylton N, Rosen M, et al,. MRI phenotype and tumor subtype affect breast conservation eligibility and MRI accuracy in the I-SPY 1 trial. San Antonio Breast Cancer Symposium, San Antonio, 2011.
12. Rastogi P, Anderson SJ, Bear HD, et al,. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 2008; 26: 778-85.
13. Patel KM, Hannan CM, Gatti ME, Nahabedian MY,. A head-to-head comparison of quality of life and aesthetic outcomes following immediate, staged-immediate, and delayed oncoplastic reduction mammoplasty. Plast Reconstr Surg 2011; 127: 2167-75.
14. Clough KB, Lewis JS, Couturaud B, Fitoussi A, Nos C, Falcou MC,. Oncoplastic techniques allow extensive resections for breast-conserving therapy of breast carcinomas. Ann Surg 2003; 237: 26-34.
15. Chang EI, Warren Peled A, Foster RD, et al,. Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomy. Ann Surg 2012; 255: 1151-7.
16. Kronowitz SJ, Kuerer HM, Buccholz TA, Valero V, Hunt KK,. A management algorithm and practical oncoplastic surgical techniques for repairing partial mastectomy defects. Plast Reconstr Surg 2008; 122: 1631-47.
17. Caruso F, Catanuto G, De Meo L, et al,. Outcomes of bilateral mammoplasty for early stage breast cancer. Eur J Surg Oncol 2008; 34: 1143-7.
18. Losken A, Styblo TM, Carlson GW, Jones GE, Amerson BJ,. Management algorithm and outcome evaluation of partial mastectomy defects treated using reduction or mastopexy trechniques. Ann Plast Surg 2007; 59: 235-42.
19. Moody AM, Mayles WP, Bliss JM, et al,. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol 1994; 33: 106-12.
20. Iwuchukwu OC, Harvey JR, Dordea M, Critchley AC, Drew PJ,. The role of oncoplastic therapeutic mammoplasty in breast cancer surgery- a review. Surg Oncol 2012; 21: 133-41.
21. Back M, Guerrieri M, Wratten C, Steigler A,. Impact of radiation therapy on acute toxicity in breast conservation therapy for early breast cancer. Clin Oncol 2004; 16: 12-6.
22. Spear SL, Pelletiere CV, Wolfe AJ, Tsangaris TN, Pennanen MF,. Experience with reduction mammaplasty combined with breast conservation therapy in the treatment of breast cancer. Plast Reconstr Surg 2003; 111: 1102-9.
23. Goffman TE, Schneider H, Hay K, Elkins DE, Schnarrs RA, Carman C,. Cosmesis with bilateral mammoreduction for conservative breast cancer treatment. Breast J 2005; 11: 195-8.
24. Fitoussi AD, Berry MG, Famà F, et al,. Oncoplastic breast surgery for cancer: analysis of 540 consecutive cases [outcomes article]. Plast Reconstr Surg 2010; 125: 454-62.
25. Warren Peled A, Foster RD, Garwood ER,. The effects of acellular dermal matrix in expander-implant breast reconstruction after total skin-sparing mastectomy: results of a prospective practice improvement study. Plast Reconstr Surg 2012; 129: 901e-8e.
26. Nahabedian MY,. AlloDerm performance in the setting of prosthetic breast surgery, infection, and irradiation. Plast Reconst Surg 2009; 124: 1743-53.
27. Warren Peled A, Foster RD, Esserman LJ, Park CC, Hwang ES, Fowble B,. Increasing the time to expander-implant exchange after post-mastectomy radiation therapy reduces expander-implant failure. Plast Reconstr Surg 2012; 130: 503-9.
28. Alvarado MD, Malik A, Wathen KJ, Berry D, Esserman LJ, I-SPY TRIAL Investigators. Predictors of local recurrence in high risk patients undergoing neoadjuvant chemotherapy in the I-SPY 1 Trial (CALGB 150007/12 ACRIN 6657). San Antonio Breast Cancer Symposium, San Antonio, 2010.
29. Cureton EL, Alvarado MD, Yau C, et al,. Biology, not choice of mastectomy versus lumpectomy, dictates recurrence in high-risk breast cancer. American Society of Breast Surgeons Annual Meeting, Phoenix, 2012.
30. von Minckwitz G, Blohmer JU, Costa S, et al,. Neoadjuvant chemotherapy adapted by interim response improves overall survival of primary breast cancer patients- results of the GeparTrio trial. San Antonio Breast Cancer Symposium, San Antonio, 2011.
31. Losken A, Pinell XA, Eskenazi B,. The benefits of partial versus total breast reconstruction for women with macromastia. Plast Reconstr Surg 2010; 125: 1051-6.
32. Munhoz AM, Montag E, Arruda EG, et al,. Superior-medial dermoglandular pedicle reduction mammaplasty for immediate conservative breast surgery reconstruction: technical aspects and outcome. Ann Plast Surg 2006; 57: 502-8.
33. Munhoz AM, Aldrighi CM, Montag E, et al,. Outcome analysis of immediate and delayed conservative breast surgery reconstruction with mastopexy and reduction mammoplasty techniques. Ann Plast Surg 2011; 67: 220-5.